The US Accounts For Nearly Half Of Global Diabetes Drug Sales
By Tyler Durden Eli Lilly, the world’s second-largest maker of anti-diabetes drugs, has become one of several companies to fall victim to fake-but-verified Twitter accounts spreading false information last week. On November 10, a “verified” account using the handle @EliLillyandCo tweeted: “We are excited to…